| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |